Galecto, Inc. (GLTO)
NASDAQ: GLTO · IEX Real-Time Price · USD
0.621
-0.009 (-1.41%)
At close: May 17, 2024, 4:00 PM
0.622
+0.001 (0.16%)
After-hours: May 17, 2024, 6:24 PM EDT
Galecto Market Cap
Galecto has a market cap or net worth of $17.07 million as of May 17, 2024. Its market cap has decreased by -67.42% in one year.
Market Cap
17.07M
Enterprise Value
-10.10M
1-Year Change
-67.42%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $17.07M, a decrease of -95.37%. That is a compound annual growth rate of -57.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 17.10M | - |
May 15, 2024 | 17.10M | -7.07% |
May 14, 2024 | 18.40M | - |
May 13, 2024 | 18.40M | - |
May 10, 2024 | 18.40M | -3.16% |
May 9, 2024 | 19.00M | -0.52% |
May 8, 2024 | 19.10M | -1.04% |
May 7, 2024 | 19.30M | - |
May 6, 2024 | 19.30M | 1.58% |
May 3, 2024 | 19.00M | -2.06% |
May 2, 2024 | 19.40M | 5.43% |
May 1, 2024 | 18.40M | 0.55% |
Apr 30, 2024 | 18.30M | -3.68% |
Apr 29, 2024 | 19.00M | -0.52% |
Apr 26, 2024 | 19.10M | 5.52% |
Apr 25, 2024 | 18.10M | -0.55% |
Apr 24, 2024 | 18.20M | -4.21% |
Apr 23, 2024 | 19.00M | 2.70% |
Apr 22, 2024 | 18.50M | - |
Apr 19, 2024 | 18.50M | -5.13% |
Apr 18, 2024 | 19.50M | 6.56% |
Apr 17, 2024 | 18.30M | -1.61% |
Apr 16, 2024 | 18.60M | - |
Apr 15, 2024 | 18.60M | 0.54% |
Apr 12, 2024 | 18.50M | -2.63% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Minerva Neurosciences | 17.96M |
Cardio Diagnostics Holdings | 17.92M |
VBI Vaccines | 17.79M |
PharmaCyte Biotech | 17.63M |
Tonix Pharmaceuticals Holding | 17.46M |
Sintx Technologies | 17.20M |
Talis Biomedical | 16.95M |
Senti Biosciences | 16.75M |